RxDoctor Payments Data

Sunil Arora, MD

Interventional Pain Medicine · Wilmington, NCNPI 1558366385

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,741 of the $6,088 with a category attached, or 77.9%. 15 manufacturers reported payments, led by Boston Scientific at 53.8% of the total. 2025 is the largest year on record at $3,055, more than ten times the $140 reported in 2019.

$6,088in general payments, 2019–2025

Across 221 payments — averaging $27.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Abbott$1K
  • SPR Therapeutics, Inc$450
  • Nevro Corp.$414
  • Medtronic$189
  • Globus Medical$150
  • plus $444 from 9 others

What the payments were for

  • Travel & lodging$1,34722%
  • Food & beverage$4,74178%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,088 in reported general payments places this provider in the 65th percentile of 45 interventional pain medicine providers in North Carolina.

See all interventional pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$530,652
Medicare patients
577
Services billed
21,310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine13$5,233
Fentanyl15$1,353
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen69$1,351
Gabapentin110$1,259
Morphine Sulfate ErMorphine Sulfate34$765
Methadone Hcl40$654
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$483
Oxycodone Hcl24$429
Tizanidine Hcl38$328
Pregabalin29$265
Methocarbamol17$260
Tramadol Hcl40$222
Topiramate14$207
Duloxetine Hcl11$168
Meloxicam27$151

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →